醒脑静注射液治疗急性脑梗死的临床效果观察

To Study Clinical Effect for the Treatment of Xingnaojing Injection on Acute Cerebral Infarction

目的探究醒脑静治疗急性脑梗死的临床效果。方法选取我院2014年3月至2016年4月收治的126例急性脑梗死患者作为研究对象,按照随机数字表法将所有患者分为试验组(65例)与对照组(61例),对照组患者予以常规基础治疗,试验组在常规基础治疗基础上联合醒脑静治疗,观察对比两组患者临床治疗效果,患者神经功能的恢复情况采用脑卒中和Barthel评量进行评估,从而对神经功能受损改善情况以及mRS评分评估患者治疗后功能恢复情况。结果研究发现,试验组治疗总有效率(90.77%)显著高于对照组(70.49%),P<0.05,差异具有统计学意义;治疗前两组患者NIHSS评分及Barthel指数量表评分对比均无明显差异,P>0.05,治疗后两组患者均明显改善,试验组改善程度优于对照组,并且治疗后试验组mRS评分0~2分的患者明显多于对照组,P<0.05,差异具有统计学意义。结论醒脑静辅助治疗急性脑梗死的临床效果显著,对患者的神经功能受损恢复具体明显的治疗作用,具有较高临床应用价值,可广泛推广应用。

Objective To explore the clinical effect for the treatment of Xingnaojing injection on acute cerebral infarction. Methods We selected 126 cases of acute cerebral infarction patients treated in our hospital from March 2014 to April 2016 as the research object. All patients were divided into experimental group （65 cases） and control group （61 cases） according to the method of random Numbers table. And the control group patients treated on a regular treatment, the experimental group treated on the regular treatment and xingnaojing injection. The clinical effects be compared with the two groups of patients, and we take NIHSS score to evaluate neurologie deficits in patients before and after treatment, take Barthel index scale to assess patients daily life ability before and after treatment as well as evaluate neurologic functional recovery after treatment in patients with mRS score. Results The study found that the experimental group total effective rate （90.77%） was significantly higher than that of control group （70.49%）, P〈0.05, the difference is statistically significant; NIHSS score and Barthel index scale of two groups of patients before treatment had no obvious difference, P〉0.05, but those of two groups of patients were significantly improved after treatment, and the experimental group is better than that of control group. The number of mRS score 0-2 points in experimental group is significantly more than that of control group after treatment, P〈0.05, the difference is statistically significant. Conclusion The treatment clinical effect of Xingnaojing injection on acute cerebral infarction is remarkable, can well improve the patients＇ neurologic deficits, and can improve patients＇ daily life ability. It has high clinical value, which can be widely applied.